The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Cassie Hill, partner at Mishcon de Reya, discusses rebuilding client relationships after maternity leave and the pressures facing women at a pivotal stage of their career
PE-backed practices now comprise the majority of ranked firms for patent prosecution in the Netherlands, but competitors are confident about their decision to remain independent
By accepting a relatively small sample of infringing content to grant worldwide relief, a UK court has adopted a pragmatic approach that could reduce the time and expense involved in huge enforcement actions
Attorney Oran Friar and trainee attorney Harry Cunliffe at Reddie & Grose, share that patent filings for clinical LLMs are surging, but success in the UK and Europe hinges on demonstrating technical innovation
With relatively high opposition rates to granted food chemistry patents, Emily Flood and Gamze Gezer-Voerknecht of NLO explain how innovators can protect their intellectual property in an increasingly competitive and fast-moving market
Igor Charles and Franck Soutoul of INLEX examine a Paris Court of Appeal ruling that fully invalidated a ‘Richard Mille’ trademark for fraud despite limits on protection based on reputation
David Ives, Laura Houston, and Richard Barker of Slaughter and May examine the UK High Court’s ruling and assess its implications for AI developers, rights holders, and future appeals
